Medscape InDiscussion: Bladder Cancer

Dr Cheryl Lee and Diane Zipursky Quale, Co-founder and Director of the Bladder Cancer Advocacy Network, discuss successes and ongoing efforts to level the playing field for those who experience bladder cancer. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/987109). The topics and discussions are planned, produced, and reviewed indepe...

Drs Cheryl Lee and Shekinah Elmore talk about how stereotactic body radiation therapy (SBRT) is being used in the treatment of oligometastatic bladder cancer — and how it's making a difference in patients' lives. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/987108). The topics and discussions are planned, produced, and reviewed ind...

Drs Cheryl Lee and Andrea Apolo discuss combination systemic therapy strategies for urothelial carcinoma, including dose de-escalation for toxicity reduction, and how ctDNA efforts are paving the way for precision medicine with the promise of biomarkers. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/987107). The topics and discussio...

Drs Cheryl Lee and Tom Powles talk about ctDNA and personalized medicine approaches for advanced bladder cancer as we sit at the precipice of change. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/987106). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US...

Drs Cheryl Lee and Karim Chamie talk about efforts to develop nogapendekin alfa, aka N-803, and where it may fit into the shifting treatment paradigm for non-muscle invasive bladder cancer. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/987105). The topics and discussions are planned, produced, and reviewed independently of advertise...

Drs Cheryl Lee and Stephen Boorjian share detailed insights about a model drug development partnership involving the first-in-class therapy for BCG-unresponsive non–muscle-invasive bladder cancer. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/987104). The topics and discussions are planned, produced, and reviewed independently of ad...

Drs Cheryl Lee and Sima Porten discuss urinary biomarkers, enhanced cystoscopy, treatments on the horizon, and communication with team members from the cytopathology lab using the PARIS classification. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/970416). The topics and discussions are planned, produced, and reviewed independently...

Drs Cheryl Lee and Angela Smith discuss bladder cancer research focused on disparities in healthcare affecting women and minorities. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/970415). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare profe...

Drs Cheryl Lee and Sophia Kamran discuss the exciting and evolving role of radiation therapy in treating bladder cancer. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/970414). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. Re...

Drs Cheryl Lee and Peter Black share exciting new ways to use liquid biopsy ctDNA testing for bladder cancer diagnostics and patient monitoring. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/970413). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US heal...

Drs Cheryl Lee and Matthew Galsky superbly synthesize the latest critical elements for sequencing perioperative bladder cancer therapies. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/970412). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare...

Bladder cancer surgeons, Drs Cheryl Lee and Khurshid Guru are inspired by a recent Swedish study and discuss aggregate surgical outcomes data comparing their different surgical approaches. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/970411). The topics and discussions are planned, produced, and reviewed independently of advertiser...